Unfreezing structural biology for drug discovery

Structure-based drug discovery relies on three-dimensional protein structures to provide the atomic blueprints for small-molecule design, indicating where to place each atom to maximize favorable interactions. The advent of cryo-cooling crystals in crystallography greatly accelerated the ease and accessibility of structural data, making it a mainstay of most drug discovery efforts. However, despite its successes, including producing numerous clinically successful molecules, cryo-cooled samples only tell part of the structural story: they may leave out dynamic details or introduce artifacts that may lead drug discovery campaigns astray. In this Perspective, we highlight recent studies characterizing temperature-sensitive structural phenomena observed by crystallography. We showcase how leveraging information on rare, hidden conformational states informs ligand discovery via molecular docking. This demonstrates the value of performing structural studies at elevated temperatures, closer to where biology occurs, to 'unfreeze' structural ensembles for drug discovery and design.